🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-18
Trial ID
NCT06878833
Treatments Being Tested
International Observational Registry on Schizophrenia...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT01026285
Treatments Being Tested
To evaluate the efficacy and safety of adjunctive pimavanserin compared wit...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-04
Trial ID
NCT02970305
Treatments Being Tested
This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect o...
Status
Completed
Location
Nucleus Network
Start Date
2023-05-16
Trial ID
NCT05857566
Treatments Being Tested
To explore the efficacy of SPD489, as adjunctive therapy to a stable dose o...
Status
Completed
Location
K&S Professional Research Services
Start Date
2009-09-14
Trial ID
NCT00922272
Treatments Being Tested
SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06060886
Treatments Being Tested
The overall purpose is to determine research based 'next-steps' for outpati...
Status
Completed
Location
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Start Date
2012-12
Trial ID
NCT01421342
"Negative" symptoms are a major challenge for people with schizophrenia (SZ...
Status
Enrolling By Invitation
Location
Tianjin Anding Hospital
Start Date
2023-09-26
Trial ID
NCT07356765
Having a diagnosis of schizophrenia or bipolar disorder and being treated w...
Status
Completed
Location
The University of Texas Health Science Center At San Antonio
Start Date
2007-08
Trial ID
NCT00538642
Treatments Being Tested